Matthew Plunkett Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Plunkett.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Plunkett. Matthew Plunkett is a EVP, Chief Business Officer in CTI BIOPHARMA CORP ($CTIC) and a EVP, Corporate Development in CTI BIOPHARMA CORP ($CTIC) and a Chief Financial Officer in Nkarta, Inc. ($NKTX).
Address: 3101 WESTERN AVENUE, SUITE 600 SEATTLE 98121 WA
Companies in which Matthew Plunkett is an Insider
CTI BIOPHARMA CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Plunkett: EVP, Chief Business Officer, EVP, Corporate Development
Holdings: 526,210 shares
Current Value: $2,457,401
Latest Transaction: Mar 06 2017
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nkarta, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Plunkett: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Jul 13 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew Plunkett
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 13 2020 | NKTX | Nkarta, Inc. | Plunkett Matthew | Chief Financial Off ... | Option Exercise | A | 18.00 | 77,800 | 1,400,400 | 77,800 | |
| Jul 13 2020 | NKTX | Nkarta, Inc. | Plunkett Matthew | Chief Financial Off ... | Option Exercise | A | 18.00 | 77,800 | 1,400,400 | 77,800 | |
| Mar 06 2017 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Option Exercise | A | 4.33 | 60,000 | 259,800 | 60,000 | |
| Mar 23 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Payment of Exercise | F | 0.55 | 63,874 | 35,016 | 526,210 | 590.1 K to 526.2 K (-10.82 %) |
| Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.60 | 900 | 536 | 590,084 | 591 K to 590.1 K (-0.15 %) |
| Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.60 | 1,220 | 726 | 590,984 | 592.2 K to 591 K (-0.21 %) |
| Mar 04 2016 | CTIC | CTI BIOPHARMA CORP | Plunkett Matthew | EVP, Chief Business ... | Sell | S | 0.59 | 500 | 297 | 592,204 | 592.7 K to 592.2 K (-0.08 %) |